ReviewPatient preference and adherence2014

Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical review.

Emilio BesadaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.